tiprankstipranks
Genesis Healthcare (DE:SH11)
FRANKFURT:SH11

Genesis Healthcare (SH11) Stock Price & Analysis

0 Followers

SH11 Stock Chart & Stats

Day’s Range€0.38 - €0.46
52-Week Range― - ―
Previous Close€0.38
Volume0.00
Average Volume (3M)N/A
Market Cap
$180.26K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Nov 09, 2020
-€0.02
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Options Prices

Currently, No data available
---

Ownership Overview

0.00%0.00%<0.01%100.00%
0.00%
Insiders
0.00%
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors

SH11 FAQ

What was Genesis Healthcare’s price range in the past 12 months?
Currently, no data Available
What is Genesis Healthcare’s market cap?
Currently, no data Available
When is Genesis Healthcare’s upcoming earnings report date?
Genesis Healthcare’s upcoming earnings report date is Nov 09, 2020 which is 1271 days ago.
    How were Genesis Healthcare’s earnings last quarter?
    Genesis Healthcare released its earnings results on Aug 10, 2020. The company reported -€0.112 earnings per share for the quarter, missing the consensus estimate of -€0.024 by -€0.088.
      Is Genesis Healthcare overvalued?
      According to Wall Street analysts Genesis Healthcare’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Genesis Healthcare pay dividends?
        Genesis Healthcare does not currently pay dividends.
        What is Genesis Healthcare’s EPS estimate?
        Genesis Healthcare’s EPS estimate is -€0.02.
          How many shares outstanding does Genesis Healthcare have?
          Currently, no data Available
          What happened to Genesis Healthcare’s price movement after its last earnings report?
          Genesis Healthcare reported an EPS of -€0.112 in its last earnings report, missing expectations of -€0.024. Following the earnings report the stock price went down -0.606%.
            Which hedge fund is a major shareholder of Genesis Healthcare?
            Currently, no hedge funds are holding shares in DE:SH11
            ---

            Genesis Healthcare Stock Smart Score

            Company Description

            Genesis Healthcare

            Genesis Healthcare, Inc. is a holding company, which engages in the provision of inpatient services through skilled nursing and assisted and senior living communites. It also offers rehabilitation and respiratory therapy services. It operates through the following segments: Inpatient Services, Rehabilitation Therapy Services, and Other Services. The Inpatient Services segment manages operation of skilled nursing facilities and assisted/senior living facilities. The Rehabilitation Therapy Services segment provides rehabilitation and respiratory therapy services. The Other Services segment comprises of other specialty medical services, including physician services, staffing services, and other healthcare related services. The company was founded in 1985 and is headquartered in Kennett Square, PA.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            HCA Healthcare
            Tenet Healthcare
            Universal Health
            Genesis Healthcare
            Humana
            Popular Stocks
            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis